ERDAT, E. C. Et Al. 2023. Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRC. JOURNAL OF GASTROINTESTINAL CANCER , vol.54, no.3 , 897-902.

ERDAT, E. C., KÖKSOY, E. B., & UTKAN, G., (2023). Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRC. JOURNAL OF GASTROINTESTINAL CANCER , vol.54, no.3, 897-902.

ERDAT, EFE, ELİF BERNA KÖKSOY, And GÜNGÖR UTKAN. "Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRC," JOURNAL OF GASTROINTESTINAL CANCER , vol.54, no.3, 897-902, 2023

ERDAT, EFE C. Et Al. "Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRC." JOURNAL OF GASTROINTESTINAL CANCER , vol.54, no.3, pp.897-902, 2023

ERDAT, E. C. KÖKSOY, E. B. And UTKAN, G. (2023) . "Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRC." JOURNAL OF GASTROINTESTINAL CANCER , vol.54, no.3, pp.897-902.

@article{article, author={EFE CEM ERDAT Et Al. }, title={Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRC}, journal={JOURNAL OF GASTROINTESTINAL CANCER}, year=2023, pages={897-902} }